Therefore, we investigated the potential of plasma exosomal proteins PSMA and caveolin-1 as liquid biopsy biomarkers for PCa in early diagnosis and progression prediction by evaluating their relationships with standard prognostic parameters. The gene discussed is CAV1; the disease is posterior cortical atrophy.